OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
439090$16740.0056

Manyo Factory Co Ltd

Personal ProductsVerified

Manyo Factory Co Ltd maintains a strong liquidity position with a current ratio of 17.07, significantly above the industry median, and holds KRW 38.7 billion in cash and equivalents, representing 29.2% of total assets. The company's price-to-book ratio of 2.24 and price-to-tangible-book ratio of 2.24 suggest a premium valuation relative to its book value, while a debt-to-equity ratio of 0.03 indicates minimal leverage. Profitability metrics show a return on equity (ROE) of 7.44% and return on assets (ROA) of 6.88%, both exceeding the industry median for personal products firms. Gross margin stands at 59.9%, with operating margin at 9.4%, reflecting efficient cost control and pricing power in its domestic and international markets. The company operates under multiple brand names, including Manyo Factory, Our Vegan, and Vanilla Boutique, and distributes products domestically and internationally. Revenue concentration data is not disclosed, but the company's geographic exposure is split between domestic and overseas markets, with no single region accounting for a majority of sales. Outlook for the current fiscal year shows a revenue growth trajectory, supported by a free cash flow of KRW 8.1 billion and operating cash flow of KRW 11.1 billion. Capital expenditures were negative KRW 2.6 billion, indicating asset sales or reduced investment in the period. The company's price-to-earnings ratio of 30.05 suggests a relatively high valuation compared to earnings. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and high cash reserves reduce financial leverage risk. No dilution pressure is expected in the near term, as shares outstanding remain unchanged between basic and diluted measures. Recent filings and transcripts do not disclose material events affecting the company's operations or financial position. The company continues to operate under its core business model, with no significant changes in strategy or capital structure reported in the latest available data.

30-day price · 439090+5490.00 (+46.1%)
Low$11730.00High$18300.00Close$17390.00As of12 May, 00:00 UTC
Profile
CompanyManyo Factory Co Ltd
Ticker439090.KQ
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Manyo Factory Co Ltd is a Korea-based company engaged in the manufacture and sale of cosmetics, including skin care products such as cleansing, ampoules, and essences, and operates under brand names Manyo Factory, Our Vegan, and Vanilla Boutique.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry with a confidence level of 0.92.

Manyo Factory Co Ltd maintains a strong liquidity position with a current ratio of 17.07, significantly above the industry median, and holds KRW 38.7 billion in cash and equivalents, representing 29.2% of total assets. The company's price-to-book ratio of 2.24 and price-to-tangible-book ratio of 2.24 suggest a premium valuation relative to its book value, while a debt-to-equity ratio of 0.03 indicates minimal leverage. Profitability metrics show a return on equity (ROE) of 7.44% and return on assets (ROA) of 6.88%, both exceeding the industry median for personal products firms. Gross margin stands at 59.9%, with operating margin at 9.4%, reflecting efficient cost control and pricing power in its domestic and international markets. The company operates under multiple brand names, including Manyo Factory, Our Vegan, and Vanilla Boutique, and distributes products domestically and internationally. Revenue concentration data is not disclosed, but the company's geographic exposure is split between domestic and overseas markets, with no single region accounting for a majority of sales. Outlook for the current fiscal year shows a revenue growth trajectory, supported by a free cash flow of KRW 8.1 billion and operating cash flow of KRW 11.1 billion. Capital expenditures were negative KRW 2.6 billion, indicating asset sales or reduced investment in the period. The company's price-to-earnings ratio of 30.05 suggests a relatively high valuation compared to earnings. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and high cash reserves reduce financial leverage risk. No dilution pressure is expected in the near term, as shares outstanding remain unchanged between basic and diluted measures. Recent filings and transcripts do not disclose material events affecting the company's operations or financial position. The company continues to operate under its core business model, with no significant changes in strategy or capital structure reported in the latest available data.
Key takeaways
  • Strong liquidity position with a current ratio of 17.07 and KRW 38.7 billion in cash and equivalents.
  • High profitability with ROE of 7.44% and ROA of 6.88%, outperforming industry medians.
  • Premium valuation metrics (P/B 2.24, P/E 30.05) suggest market confidence in growth and brand strength.
  • Low financial leverage and no immediate dilution or liquidity risks detected.
  • Geographic diversification across domestic and international markets, though revenue concentration details are not disclosed.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$113.02B
Gross profit$67.80B
Operating income$10.64B
Net income$9.13B
R&D
SG&A
D&A
SBC
Operating cash flow$11.10B
CapEx-$2.62B
Free cash flow$8.12B
Total assets$132.70B
Total liabilities$10.02B
Total equity$122.68B
Cash & equivalents$38.71B
Long-term debt$3.28B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$113.02B$10.64B$9.13B$8.12B
FY-1$127.92B$18.22B$16.37B$15.90B
FY-2$105.00B$15.86B$11.63B$9.70B
FY-3$101.84B$24.49B$17.30B$15.88B
FY-4$62.62B$17.71B$14.17B$14.52B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$132.70B$122.68B$38.71B
FY-1$129.50B$113.80B$43.40B
FY-2$105.47B$97.05B$45.45B
FY-3$62.79B$52.15B$36.89B
FY-4$41.29B$32.75B$26.00B
PeriodOCFCapExFCFSBC
FY0$11.10B-$2.62B$8.12B
FY-1$18.11B-$1.73B$15.90B
FY-2$9.44B-$2.97B$9.70B
FY-3$14.72B-$2.17B$15.88B
FY-4$15.73B-$291.5M$14.52B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$25.75B$2.03B$1.75B$357.9M
FQ-1$28.70B$4.02B$2.69B$2.52B
FQ-2$31.69B$2.98B$1.90B$2.21B
FQ-3$26.87B$1.42B$2.78B$3.04B
FQ-4$31.46B$3.62B$3.61B$3.82B
FQ-5$28.82B$2.56B$3.21B$3.50B
FQ-6$36.63B$8.31B$6.59B$6.96B
FQ-7$31.01B$4.06B$2.95B$1.62B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$132.70B$122.68B$38.71B
FQ-1$135.52B$120.56B$31.56B
FQ-2$126.45B$117.52B$48.70B
FQ-3$130.64B$116.57B$38.72B
FQ-4$129.50B$113.80B$43.40B
FQ-5$122.37B$110.42B$37.06B
FQ-6$118.27B$107.02B$39.74B
FQ-7$118.27B$100.21B$50.78B
PeriodOCFCapExFCFSBC
FQ0$11.10B-$2.62B$357.9M
FQ-1$8.99B-$811.8M$2.52B
FQ-2-$4.21B-$103.4M$2.21B
FQ-3-$5.60B-$73.0M$3.04B
FQ-4$18.11B-$1.73B$3.82B
FQ-5$11.43B-$1.63B$3.50B
FQ-6$7.27B-$1.58B$6.96B
FQ-7$7.60B-$1.61B$1.62B
Valuation
Market price$16740.00
Market cap$274.26B
Enterprise value$238.83B
P/E30.1
Reported non-GAAP P/E
EV/Revenue2.1
EV/Op income22.5
EV/OCF21.5
P/B2.2
P/Tangible book2.2
Tangible book$122.68B
Net cash$35.43B
Current ratio17.1
Debt/Equity0.0
ROA6.9%
ROE7.4%
Cash conversion1.2%
CapEx/Revenue-2.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric439090Activity
Op margin9.4%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin8.1%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin60.0%60.1% medp25 60.1% · p75 60.1%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-2.3%-2.3% medp25 -4.4% · p75 -1.1%above median
Debt / equity3.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 02:04 UTC#b8813358
Market quoteclose KRW 16740.00 · shares 0.02B diluted
no public URL
2026-05-12 02:04 UTC#6ce7ee7e
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 02:06 UTCJob: 7cbf36ab